Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes.
Letsas
Konstantinos P
KP
Efremidis
Michael
M
Sideris
Antonios
A
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D015994:Incidence; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors; D013015:Sotalol / Q000008:administration & dosage / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents; D013015:Sotalol